Page last updated: 2024-09-02

oxymatrine and sulfadiazine

oxymatrine has been researched along with sulfadiazine in 2 studies

Compound Research Comparison

Studies
(oxymatrine)
Trials
(oxymatrine)
Recent Studies (post-2010)
(oxymatrine)
Studies
(sulfadiazine)
Trials
(sulfadiazine)
Recent Studies (post-2010) (sulfadiazine)
410273,178156500
412162703,178156500

Protein Interaction Comparison

ProteinTaxonomyoxymatrine (IC50)sulfadiazine (IC50)
Carbonic anhydrase 1Homo sapiens (human)0.341
Carbonic anhydrase 2Homo sapiens (human)0.341
Carbonic anhydrase 6Homo sapiens (human)0.341

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chen, XF; Chen, YL; Feng, KR; Kong, DX; Li, WX; Niu, L; Tang, JF; Wang, B; Wang, XY; Wu, CZ; Wu, YL; Yang, LQ; Zhang, H; Zhang, ML; Zhang, SQ1

Other Studies

2 other study(ies) available for oxymatrine and sulfadiazine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Animals; Blood-Brain Barrier; Dysbiosis; Encephalomyelitis, Autoimmune, Experimental; Gastrointestinal Microbiome; Homeostasis; Mice; Mice, Inbred C57BL; Multiple Sclerosis; RNA, Ribosomal, 16S; Sulfadiazine; Tandem Mass Spectrometry

2022